Inventor · disambiguated record
William V. Williams
Also filed as: AYYAVOO VELPANDI · WILLIAMS WILLIAM · WILLIAMS WILLIAM V · WILLIAMS WILLIAM VALENTINE
27 granted patents·10 pending applications·2,311 citations·filing 1990–2025
98Inventor score
Top patents by PatentIndex Score
37 records- 0199US5817637AGenetic immunizationUNIV PENNSYLVANIA·Filed 1997·Granted Oct 6, 1998·381 cites·34 claims
- 0299US5593972AGenetic immunizationWISTAR INST·Filed 1993·Granted Jan 14, 1997·807 cites·9 claims
- 0397US11337927B2Sustained-release dosage forms of ruxolitinibINCYTE CORP·Filed 2020·Granted May 24, 2022·12 cites·34 claims
- 0497US10874616B2Sustained-release dosage forms of ruxolitinibINCYTE CORP·Filed 2018·Granted Dec 29, 2020·17 cites·36 claims
- 0597US5830876AGenetic immunizationUNIV PENNSYLVANIA·Filed 1995·Granted Nov 3, 1998·207 cites·17 claims
- 0696US10166191B2Sustained-release dosage forms of ruxolitinibINCYTE CORP·Filed 2013·Granted Jan 1, 2019·32 cites·12 claims
- 0795US5981505ACompositions and methods for delivery of genetic materialUNIV PENNSYLVANIA·Filed 1994·Granted Nov 9, 1999·197 cites·75 claims
- 0894US5637677ABiologically active compounds and methods of constructing and using the sameUNIV PENNSYLVANIA·Filed 1992·Granted Jun 10, 1997·138 cites·35 claims
- 0990US5714316AChimeric envelope proteins for viral targetingWISTAR INST·Filed 1993·Granted Feb 3, 1998·99 cites·11 claims
- 1090US2025064746A1Sustained-release dosage forms of ruxolitinibINCYTE CORP·Filed 2024·Application pending·0 cites
- 1188US5556744AMethods and compositions for diagnosing and treating certain HIV infected patientsUNIV PENNSYLVANIA·Filed 1994·Granted Sep 17, 1996·86 cites·2 claims
- 1287US2025312279A1Sustained-release dosage forms of ruxolitinibINCYTE CORP·Filed 2025·Application pending·0 cites
- 1386US11896717B2Sustained-release dosage forms of ruxolitinibINCYTE CORP·Filed 2022·Granted Feb 13, 2024·0 cites·23 claims
- 1486US5837460AMethods of identifying biologically active receptor-binding peptidesUNIV PENNSYLVANIA·Filed 1996·Granted Nov 17, 1998·77 cites·13 claims
- 1584US6248565B1Immunization with plasmid encoding immunogenic proteins and intracellular targeting sequencesUNIV PENNSYLVANIA·Filed 2000·Granted Jun 19, 2001·21 cites·35 claims
- 1684US5840300AMethods and compositions comprising single chain recombinant antibodiesUNIV PENNSYLVANIA·Filed 1995·Granted Nov 24, 1998·46 cites·5 claims
- 1783US11576865B2Sustained-release dosage forms of ruxolitinibINCYTE CORP·Filed 2022·Granted Feb 14, 2023·0 cites·30 claims
- 1883US8304234B2Compositions and methods for delivery of genetic materialWEINER DAVID B·Filed 2005·Granted Nov 6, 2012·4 cites·28 claims
- 1982US11576864B2Sustained-release dosage forms of ruxolitinibINCYTE CORP·Filed 2022·Granted Feb 14, 2023·0 cites·30 claims
- 2082US5574009AMethod of stimulating myelination of cellsUNIV PENNSYLVANIA·Filed 1994·Granted Nov 12, 1996·43 cites·5 claims
- 2180US2022211631A1Sustained-release dosage forms of ruxolitinibINCYTE CORP·Filed 2022·Application pending·0 cites
- 2279US6468982B1Genetic immunizationUNIV PENNSYLVANIA·Filed 1997·Granted Oct 22, 2002·38 cites·15 claims
- 2375US6087486ANucleotide sequences encoding vpr receptor proteinUNIV PENNSYLVANIA·Filed 1998·Granted Jul 11, 2000·31 cites·20 claims
- 2470US6228621B1Plasmids encoding immunogenic proteins and intracellular targeting sequencesUNIV PENNSYLVANIA·Filed 1997·Granted May 8, 2001·25 cites·40 claims
- 2567US2010113416A1Janus kinase inhibitors for treatment of dry eye and other eye related diseasesFRIEDMAN PAUL A·Filed 2009·Application pending·0 cites
- 2666US5219837AMethod of stimulating myelination of cellsUNIV PENNSYLVANIA·Filed 1990·Granted Jun 15, 1993·28 cites·4 claims
- 2764US2012301464A1Janus kinase inhibitors for treatment of dry eye and other eye related diseasesFRIEDMAN PAUL A·Filed 2012·Application pending·0 cites
- 2863US2020093825A1Janus kinase inhibitors for treatment of dry eye and other eye related diseasesINCYTE CORP·Filed 2019·Application pending·0 cites
- 2963US2017087158A1Janus kinase inhibitors for treatment of dry eye and other eye related diseasesINCYTE CORP·Filed 2016·Application pending·0 cites
- 3060US2023277640A1Whole-cell cancer vaccines and methods for selection thereofBRIACELL THERAPEUTICS CORP·Filed 2022·Application pending·0 cites
- 3157US2003144479A1Biologically active compounds and methods of constructing and using the sameFiled 2002·Application pending·0 cites
- 3251US11559574B2Whole-cell cancer vaccines and methods for selection thereofBRIACELL THERAPEUTICS CORP·Filed 2018·Granted Jan 24, 2023·0 cites·81 claims
- 3351US5338829APeptides derived from human immunodeficiency virus-1 GP160UNIV PENNSYLVANIA·Filed 1992·Granted Aug 16, 1994·9 cites·5 claims
- 3449US2025186568A1Cancer vaccines and methods of use thereofBRIACELL THERAPEUTICS CORP·Filed 2023·Application pending·0 cites
- 3548US7001759B1Compositions and methods for delivery of genetic materialWISTAR INST·Filed 1999·Granted Feb 21, 2006·11 cites·8 claims
- 3638US6372884B1Biologically active compounds and methods of constructing and using the sameUNIV PENNSYLVANIA·Filed 1996·Granted Apr 16, 2002·1 cites·2 claims
- 3733US6667157B1Compositions and methods for the abrogation of cellular proliferation utilizing the human immunodeficiency virus VPR proteinUNIV PENNSYLVANIA·Filed 1995·Granted Dec 23, 2003·1 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when William V. Williams files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →